Delayed vasodilatory response to methylnicotinate in patients with unipolar depressive disorder

J Affect Disord. 2004 Oct 15;82(2):285-90. doi: 10.1016/j.jad.2003.11.005.

Abstract

Background: Recent evidence has suggested an important role for lipids in the etiology and treatment of depression. Methylnicotinate-induced vasodilation can be used to investigate lipid-dependent signalling mechanisms involving the phospholipase A2 (PLA2)/cyclooxygenase pathway, an important signalling system involved in the action of several neurotransmitters including serotonin. To investigate whether abnormalities in this signalling system may occur in depressive illness, we undertook a study of methylnicotinate response in unipolar depression (UD).

Methods: Methylnicotinate was applied to the forearm of 20 patients with depression and 38 age and sex-matched healthy volunteers (HV). The resulting erythema was assessed over a 15-min period.

Results: Methylnicotinate-induced erythema was reduced in subjects with depression compared to HV at 5 min after application, it returned to normal after 15 min. Thus, although the maximal response to methylnicotinate appears normal, patients with UD exhibit an apparently delayed response.

Limitations: The major limitation is that all unipolar patients were medicated at the time of testing.

Conclusions: Our results support the hypothesis that UD may be associated with abnormalities in lipid-associated signalling systems, and may provide insight into how lipid intake may modulate depressive symptoms.

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / physiopathology*
  • Dietary Fats / administration & dosage
  • Dietary Fats / adverse effects
  • Female
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Nicotinic Acids*
  • Patch Tests
  • Phospholipases A / physiology*
  • Phospholipases A2
  • Prostaglandin-Endoperoxide Synthases / physiology*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • Skin / blood supply
  • Vasodilation / drug effects*
  • Vasodilation / physiology

Substances

  • Antidepressive Agents
  • Dietary Fats
  • Lipids
  • Nicotinic Acids
  • Serotonin Uptake Inhibitors
  • methyl nicotinate
  • Prostaglandin-Endoperoxide Synthases
  • Phospholipases A
  • Phospholipases A2